플러스100%마이너스

  • 화면크기
통합검색

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of a Polyphenolic Extract (Hibiscus sabdariffa and Lippia citriodora) for Reducing Blood Pressure in Prehypertensive and Type 1 Hypertensive Subjects.

Authors

Marhuenda J, Pérez-Piñero S, Arcusa R, Victoria-Montesinos D, Cánovas F, Sánchez-Macarro M, García-Muñoz AM, Querol-Calderón M, López-Román FJ.

Journal

Molecules.

Year

2021

Vol (Issue)

26(6)

Page

1783.

doi

10.3390/molecules26061783.

PMID

33810049

Url

http://www.ncbi.nlm.nih.gov/pubmed/33810049

MeSH

Adult
Blood Pressure / drug effects*
Double-Blind Method
Female
Hibiscus / chemistry*
Humans
Hypertension* / drug therapy
Hypertension* / physiopathology
Lippia / chemistry*
Male
Middle Aged
Phytotherapy
Plant Extracts / administration & dosage*
Plant Extracts / chemistry
Polyphenols / administration & dosage*
Polyphenols / chemistry

Keywords

Hibiscus sabdariffa; Lippia citriodora; blood pressure; hypertension; polyphenol.

한글 키워드

KMCRIC summary and commentary

없음

Korean Study

N

Abstract

Hypertension is an important factor of cardiovascular diseases and contributes to their negative consequences including mortality. The World Health Organization estimated that 54% of strokes and 47% of cases of ischemic heart illness are related to high blood pressure. Recently, Hibiscus sabdariffa (HS) and Lippia citriodora (LC) have attracted scientific interest, and they are recognized for their high content of polyphenols as these may prevent several disease factors, such as hypertension. The aim of the present study is to determine if supplementation with an HS-LC blend (MetabolAid®) may be effective for the treatment of type 1 hypertensive sedentary populations. A total of 80 type 1 hypertensive subjects of both sexes were included in the study and were treated with placebo or the HS-LC extract, and both groups were treated over 84 days. The blood pressure (diastolic, systolic, and pulse pressure) was measured throughout the day, for each of the days of the study duration and determined using Ambulatory Blood Pressure Monitoring (ABPM). Physical activity was determined throughout the study to ensure similar conditions related to exercise. The results showed the capacity for reducing the blood pressure parameters in the case of the HS-LC extract. The daily consumption of the HS-LC extract but not the placebo over 84 days was able to reduce the daytime parameters related to blood pressure. The most remarkable results were observed in the measurements performed during the daytime, especially in the systolic blood pressure showing statistically significant variation.

국문초록

Language

영어

첨부파일